University of Virginia

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1819-01-01

Employees: 10K

Market Cap: -

Website: http://www.virginia.edu

Clinical Trials

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Phase 3

Recruiting

Conditions: Breast Cancer Female

Interventions: Drug: Tamoxifen, Letrozole, Anastrozole, or Exemestane

First Posted Date: 2024-07-18

Last Posted Date: 2024-08-21

Lead Sponsor: University of Virginia

Target Recruit Count: 354

Registration Number: NCT06507618

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Phase 1

Recruiting

Conditions: Pancreas Cancer
Pancreatic Cancer

Interventions: Drug: EGFR FPBMC

First Posted Date: 2024-06-28

Last Posted Date: 2024-12-05

Lead Sponsor: University of Virginia

Target Recruit Count: 23

Registration Number: NCT06479239

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females

Not Applicable

Not yet recruiting

Conditions: Menopause

Interventions: Dietary Supplement: Berkeley Life Pro Nitrate Capsules
Behavioral: High Intensity Exercise
Behavioral: Moderate Intensity Exercise

First Posted Date: 2024-06-28

Last Posted Date: 2024-06-28

Lead Sponsor: University of Virginia

Target Recruit Count: 40

Registration Number: NCT06480695

FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Early Phase 1

Not yet recruiting

Conditions: Advanced Melanoma

Interventions: Device: Echopulse or Echopulse HD
Drug: PolyICLC

First Posted Date: 2024-06-25

Last Posted Date: 2024-07-03

Lead Sponsor: University of Virginia

Target Recruit Count: 11

Registration Number: NCT06472661

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis

Completed

Conditions: Arthropathy of Hip
Perioperative/Postoperative Complications

Interventions: Behavioral: home support, hiving alone
Behavioral: home support, living with others

First Posted Date: 2024-06-17

Last Posted Date: 2024-06-18

Lead Sponsor: University of Virginia

Target Recruit Count: 5677

Registration Number: NCT06462885

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

Phase 4

Recruiting

Conditions: Breast Cancer
Blood Loss, Surgical

Interventions: Drug: Tranexamic acid
Drug: Placebo

First Posted Date: 2024-05-24

Last Posted Date: 2024-06-05

Lead Sponsor: University of Virginia

Target Recruit Count: 100

Registration Number: NCT06428682

Locations: 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States

Effect of Nitropaste in Chest Masculinizing Surgery

Phase 4

Recruiting

Conditions: Gender Dysphoria

Interventions: Drug: Nitro-Bid 2 % Topical Ointment

First Posted Date: 2024-05-24

Last Posted Date: 2024-06-06

Lead Sponsor: University of Virginia

Target Recruit Count: 256

Registration Number: NCT06428669

Locations: 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States

Insulearn Feasibility With MDI

Not Applicable

Not yet recruiting

Conditions: Type 1 Diabetes Mellitus

Interventions: Device: InsuLearn

First Posted Date: 2024-05-13

Last Posted Date: 2024-05-13

Lead Sponsor: University of Virginia

Target Recruit Count: 10

Registration Number: NCT06411548

Locations: 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States

Optical Measurements of the Skin Surface to Infer Distinctions in Myofascial Tissue Stiffness

Not Applicable

Recruiting

Conditions: Tissue Pain

Interventions: Other: Soft tissue manipulation

First Posted Date: 2024-04-30

Last Posted Date: 2024-04-30

Lead Sponsor: University of Virginia

Target Recruit Count: 15

Registration Number: NCT06390085

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery

Early Phase 1

Recruiting

Conditions: Pain, Postoperative

Interventions: Drug: Morphine
Drug: Methadone

First Posted Date: 2024-04-29

Last Posted Date: 2024-08-09

Lead Sponsor: University of Virginia

Target Recruit Count: 40

Registration Number: NCT06387303

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy